Spruce Biosciences, Inc. announced it raised $44 Million in an initial filing from an offering of $88 Million

Company

Location

About

Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company aims to address significant unmet medical needs through innovative treatment solutions. Spruce has a particular focus on rare diseases and is committed to serving patient communities. They are known for their work in enzyme replacement therapies.